Newswire

Weatherford pharmacist joins lawmakers, peers from six states supporting bill at U.S. Capitol

Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices

Pharmacy Benefit Managers Are Killing Indie Pharmacies and Limiting Patient Choice

Rally outside Optum HQ spotlights debate over pharmacy benefits managers

Higher Drug Costs, Less Choice: How PBMs Affect Everyday Americans’ Healthcare

TRICARE becomes part of fight over pharmacy benefit managers

A PBM Oligopoly: Three Companies Control 80% Of US Prescriptions – How Can We Fix It?

States Keep Legal Pressure on PBMs Ahead of Potential FTC Suit

Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?

CVS Caremark agrees to $45M settlement with Illinois: report

Lawmakers introduce bipartisan bill aiming to crack down on drug middlemen as scrutiny ramps up

Pharmacy middlemen claim to keep prescription prices low. In fact, they’ve cost consumers billions

Insurers, employers see payoffs switching to smaller PBMs

FTC plans to sue top 3 PBMs over insulin prices: WSJ

Medicare Advantage and Consolidation’s New Frontier — The Danger of UnitedHealthcare for All

PBMs pay higher prices to their own pharmacies, FTC says

Health insurers cover fewer drugs and make them harder to get

Spanberger Joins More Than 20 Colleagues in a Bipartisan, Bicameral Effort Urging the Defense Health Agency to Increase Oversight of Its Exclusive Contract with Express Scripts

3Axis Report Scrutinizes PBM Spread Pricing Practice

Independent local pharmacies at risk as reimbursement environment prompting closures